Delivery Order SPE2DB24D3015-SPE2DB25FFXXC

Award Date 1/30/25
Potential Completion Date 1/31/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,047.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The award covers the supply of 4564755730 - VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product, with an ultimate...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,276.40, is for the supply of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 5, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,136.11, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of February 10, 2025. The contract is for the procurement of VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product. This award does not have a set-aside designation,...
This federal contract award is a delivery order with a ceiling value of $7,319.37, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication, with a completion date of February 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,819.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 10 MG CAPSULE 100S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs...
This federal contract award is a delivery order valued at $1,797.23 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through January 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $5,231.94 with a firm fixed price. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,416.77, is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
This federal contract award, valued at $10,830.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $14,590.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order that covers the supply of VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product. The award has a firm fixed price pricing type and an ultimate completion date of January 17, 2024. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFXXC
    Delivery Order

This federal contract award is a delivery order with a ceiling value of $1,807.74 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price pricing type and an ultimate completion date of January 31, 2025. No set-aside designation was used for this award.

Generated 5/1/25, 10:18 AM